New study could change how Men's UTIs are treated
NCT ID NCT06822751
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a common antibiotic for women's UTIs, fosfomycin-trometamol, works well for men with urinary tract infections. Current treatments can have serious side effects and increase antibiotic resistance. The trial will enroll 138 men in primary care and monitor for treatment failure up to 14 days after therapy ends.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ELBEUF
Elbeuf, 76500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Home hospital care for infections: when does it fail?
- New tool helps women with bladder infections skip unnecessary antibiotics
- Simple urine test could revolutionize schistosomiasis detection
- Stop the pills when symptoms vanish? landmark trial for Kids' infections
- Could a simple cream prevent painful UTIs in baby boys?
- VA hospitals aim to cut needless Pre-Surgery urine tests